About-Charitable Organization-St. Petersburg-Curing Type 1 Diabetes
JDRF is the only organization with a strategic research plan to end T1D. Our strategies include: Artificial Pancreas Systems Artificial pancreas systems will eliminate blood glucose testing and carb counting by totally automating insulin dosing, initially preventing dangerous low blood sugars and eventually ensuring ideal glucose control. Complications JDRF’s complications research is leading to therapies to treat and even reverse some of the debilitating, costly, and life-threatening complications caused by T1D. Encapsulation JDRF’s encapsulation research will restore insulin independence for 18 months to two years
by implanting newly created beta cells into a protective capsule, which eliminates the need for toxic immune suppression therapies. Type 1 diabetes in children used to be known as juvenile diabetes or insulin-dependent diabetes. Alternative Names of T1D: Insulin-dependent diabetes; Juvenile onset diabetes; Diabetes – type 1. Type 1 Diabetes – In type 1 diabetes, your immune system mistakenly destroys the cells in your pancreas that make insulin. Your body treats these cells as invaders and destroys them. This can happen over a few weeks, months, or years. When enough beta cells are destroyed, your pancreas stops making insulin, or makes too little insulin. Because the pancreas does not make insulin, insulin needs to be replaced. Insulin does not come in a pill. People with type 1 diabetes take insulin by injection with a syringe, an insulin pen, or an insulin pump. Without insulin, your blood glucose rises and is higher than normal, which is called hyperglycemia. Type 1 diabetes affects about 5% of people in the United States with diabetes. In the past type 1 diabetes was called juvenile diabetes or insulin-dependent diabetes. It’s usually first diagnosed in young people but it can occur at any age. Type 1 diabetes is much less common than type 2 diabetes. Full list of Video Credits is stored here http://broadcaster.beazil.net/public/credits/youtube/videos/41880 Priatek Plaza (also known as One Progress Plaza) is a 28-story skyscraper designed by Jung Brannen Associates located at 200 Central Avenue in downtown St. Petersburg, Florida. It was completed in 1990, and at 117.65 m (386.0 ft), it is the tallest building in the city, tallest building in Pinellas County, and has the largest tenant occupancy in a commercial office building on the entire South West coast of Florida. The tower was formerly known as the Bank of America Tower, and One Progress Plaza. On September 18, 2015, Kucera Properties announced that the tower would be renamed Priatek Plaza after the company Priatek. Priatek, who occupies about 8,000 square feet on the 23rd floor of the tower, had moved its headquarters into the tower after Kucera Properties had offered them an undisclosed amount. The official dedication ceremony for the new plaza’s name was held on September 17. 2015. The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
To sum up, the major issues that were mentioned are:
Artificial Pancreas,JDRF One Walk,2-h PG value,Beta Cell Health and Survival,mean glucose,Somogyi effect,glucose,Neuropathy,Traveling with Diabetes,Pathaway to Prevention,The Ride to Cure Diabetes,Dymelor,insulin glulisine,repaglinide,LADA,make a donation,latent autoimmune diabetes in adults,Lantus,diabetes related complications,noninsulin-dependent diabetes mellitus,starch breakdown,support,low blood glucose,GMP,funding research,Trial,protease inhibitors,donate today,diabetes mellitus,HHNS,contribute,autoimmune therapies,insulin adjustment,Fast Acting Insulin,sorbitol,donate to help,insulin reaction,IFG,St. Pete,fundraise,The Walk to Cure Diabetes,NRTIs,Children’s Congress,T1D Triggers,Blood Glucose.